(19)
(11) EP 1 220 872 A1

(12)

(43) Date of publication:
10.07.2002 Bulletin 2002/28

(21) Application number: 00966698.3

(22) Date of filing: 04.10.2000
(51) International Patent Classification (IPC)7C07K 7/08, A61K 38/10, A61P 35/00
(86) International application number:
PCT/US0021/998
(87) International publication number:
WO 0125/266 (12.04.2001 Gazette 2001/15)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 06.10.1999 US 157950 P

(71) Applicant: Pharmacia Corporation
Chicago, IL 60680-5110 (US)

(72) Inventors:
  • SHAILUBHAI, Kunwar
    Chesterfield, MO 63017 (US)
  • CURRIE, Mark, G.
    St. Charles, MO 63304 (US)

(74) Representative: Beil, Hans Christoph, Dr. 
Hansmann & Vogeser,Patent- und Rechtsanwälte,Postfach 80 01 40
65901 Frankfurt
65901 Frankfurt (DE)

   


(54) UROGUANYLIN AS AN INTESTINAL CANCER INHIBITING AGENT